SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe
- PMID: 35545022
- PMCID: PMC9087889
- DOI: 10.1016/j.stemcr.2022.04.011
SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Comment in
-
Response to: SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe.Stem Cell Reports. 2022 May 10;17(5):1014-1015. doi: 10.1016/j.stemcr.2022.04.012. Stem Cell Reports. 2022. PMID: 35545023 Free PMC article. No abstract available.
Comment on
-
The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.Stem Cell Reports. 2022 Feb 8;17(2):307-320. doi: 10.1016/j.stemcr.2021.12.011. Epub 2022 Jan 20. Stem Cell Reports. 2022. PMID: 35063125 Free PMC article.
References
-
- Constant O., Barthelemy J., Bolloré K., Tuaillon E., Gosselet F., Chable-Bessia C., Merida P., Muriaux D., Van de Perre P., Salinas S., Simonin Y. SARS-CoV-2 Poorly replicates in cells of the Human blood-brain barrier without Associated Deleterious Effects. Front. Immunol. 2021;12 doi: 10.3389/fimmu.2021.697329. - DOI - PMC - PubMed
-
- Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., Appelt-Menzel A., Cubukova A., Barenberg J., Leu J., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17:307–320. doi: 10.1016/j.stemcr.2021.12.011. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
